期刊文献+

枸地氯雷他定联合维生素D滴剂治疗慢性自发性荨麻疹的疗效观察 被引量:11

Efficacy of deloratadine citrate disodium tablets combined with vitamin D drops against chronic idiopathic urticaria
暂未订购
导出
摘要 目的观察枸地氯雷他定联合维生素D滴剂治疗血清25-(OH)维生素D含量缺乏的慢性自发性荨麻疹患者的临床疗效。方法选取2018-10至2019-09就诊于山西医科大学第一医院皮肤科门诊的血清25-(OH)维生素D含量缺乏的慢性自发性荨麻疹患者108例,按随机数字表法分为两组,每组54例。对照组予口服枸地氯雷他定片,治疗组予口服枸地氯雷他定片联合维生素D滴剂,疗程均为6周,比较两组患者的总有效率及治疗前后的每天发作次数评分、每天发作时间评分、皮肤病生活质量指数评分、血清25-(OH)维生素D含量的差异。结果治疗后治疗组总有效率83.33%,高于对照组的64.81%,差异有统计学意义(P<0.05);治疗前两组各项指标差异均无统计学意义,治疗后两组各项指标均较治疗前有改善,差异有统计学意义(P<0.05);治疗后治疗组每天发作次数评分、每天发作时间评分及DLQI评分均低于对照组,差异均有统计学意义(P<0.05);治疗组25-(OH)维生素D含量明显高于对照组,差异有统计学意义;治疗后治疗组平均血清25-(OH)维生素D含量[(59.43±10.08)nmol/L]与对照组血清25-(OH)维生素D含量[(30.19±9.60)nmol/L]相比差异有统计学意义(P<0.05)。结论血清25-(OH)维生素D含量缺乏的慢性自发性荨麻疹患者口服枸地氯雷他定片联合维生素D滴剂疗效显著,能够改善患者的生活质量,值得推广使用。 Objective To observe the clinical efficacy of desloratadine citrate disodium tablets combined with vitamin D drops against chronic spontaneous urticaria patients with serum 25-(OH)VD deficiency.Methods One hundred and eight outpatients with chronic spontaneous urticaria complicated with a deficiency of serum 25-(OH)VD content who were treated in the Dermatology Department of the First Hospital of Shanxi Medical University between October 2018 and September 2019 were divided into two groups using the random number table method:the control group(54 cases)that was given oral desloratadine citrate disodium tablets alone,and the observation group(54 cases)that was treated with oral desloratadine citrate disodium tablets combined with vitamin D drops.The course of treatment was 6 weeks.The total effective rate of patients,daily episode number scores,daily episode time scores,Dermatological Quality of Life Index(DLQI)scores and serum 25-(OH)VD content before and after treatment were compared between the two groups.Results The total effective rate in the observation group after treatment was 83.33%,higher than that in the control group(64.81%).The difference between the two groups was statistically significant(P<0.05).After treatment,the mean serum 25-(OH)VD content[(59.43±10.08)nmol/L]in the observation group was significantly different from that of the control group[(30.19±9.60)nmol/L](P<0.05).Conclusions In the clinical treatment of chronic spontaneous urticaria patients with a deficiency of serum 25-(OH)VD content,oral deloratadine citrate disodium tablets alone or in combination with vitamin D drops have good curative effect,but the latter approach is more effective in that it can significantly improve the therapeutic effect and patients’quality of life,which should be made more accessible in future clinical use.
作者 郎小青 续凤凤 郭书萍 LANG Xiaoqing;XU Fengfeng;GUO Shuping(The First Clinical College,Shanxi Medical University,Taiyuan 030001,China;Department of Dermatology,the First Hospital of Shanxi Medical University,Taiyuan 030001,China)
出处 《武警医学》 CAS 2020年第7期561-564,共4页 Medical Journal of the Chinese People's Armed Police Force
关键词 枸地氯雷他定片 维生素D滴剂 慢性自发性荨麻疹 疗效 皮肤病生活质量指数 deloratadine citrate tablets vitamin D drops 25-(OH)VD content chronic spontaneous urticaria curative effect observation
  • 相关文献

参考文献6

二级参考文献40

  • 1Juhlin L. Inhibition of cold urticaria by desloratadine[ J]. J Dermatol Treat, 2004,15( 1 ) :51 - 59,.
  • 2Ten Eick AP, Blumer JL, Reed MD. Safety of antihistamines in children[J]. Drug Saf, 2001,24(2) : 119 - 147.
  • 3Anthes JC, Richard C, West RE, et al. Functional characterization of desloratadine and other antihistamines in humane H1 receptors [J].Allergy, 2000,55 ( Suppl 63 ) : S279.
  • 4Lippert U, Moiler A, welker P, et al. Inhibition of cytokine secretion from human leukemic mast cells and basophilis by H1 and H2 receptor antagonists[J]. Exp Dermatol,2000,9(2) : 118 - 124.
  • 5Bloom M, Staudinger H, Herron J. Safety of desloratadine syrup in children[J]. Curr Med Res Opin ,2004,20(12) : 1959 - 1965.
  • 6Banfield C,Gupta S, Marino M, et al. Grapefruit juice reduces the oral bioavailability of fexofenadine but not desloratadine [ J]. Clin Pharmacokinet, 2002,41 (4) : 311 - 318.
  • 7Bachert C. Decongestant efficacy of desloratadine in patients with seasonal allergic rhinitis [ J ]. Allergy, 2001,56 ( Suppl 65 ) : S14 - S20.
  • 8Ring J,Hein R, Gauger A, et al. Once-daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria:a randomized,douhle-blind, placebo-controlled study [ J]. lnt J Dermatol, 2001,40(1):72-76.
  • 9Tagllalatela M, Castaldo P, Pannaccione A, et al. Cardiac ion channels and antihistamines: possible mechanisms of cadiotoxicity[J].Clin Exp Allergy, 1999,29( Suppl 3):S182- S189.
  • 10Kreutner W,Hey JA, Athes J, et al. Preclinical pharmacology of desloratadine, a selective and nonsedating histamine HI receptor antagonist. 2nd communication: lack of central nervous system and cardiovascular effects [ J ]. Arzneimittelforschung , 2000,50 ( 5 ) : 441 -448.

共引文献558

同被引文献109

引证文献11

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部